IMMOBILISATION SYNDROME

This adverse event was reported 213 times

These drugs are most commonly taken by patients reporting IMMOBILISATION SYNDROME:

# Drug Count
0 METHOTREXATE SODIUM 27
1 METHOTREXATE 22
2 ROSUVASTATIN 17
3 ABATACEPT 16
4 RITUXIMAB 15
5 ANAKINRA 14
6 CERTOLIZUMAB PEGOL 14
7 FUROSEMIDE 14
8 HYDROXYCHLOROQUINE SULFATE 14
9 LEFLUNOMIDE 14
See all common drugs associated with IMMOBILISATION SYNDROME

IMMOBILISATION SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PAROMOMYCIN SULFATE 4 0.0377
1 BARICITINIB 13 0.0043
2 POTASSIUM IODIDE 4 0.0027
3 EPHEDRINE HYDROCHLORIDE 1 0.0022
4 DAPRODUSTAT 4 0.0020
5 EDARAVONE 3 0.0019
6 EDOXABAN TOSYLATE 10 0.0015
7 ANDEXANET ALFA 1 0.0014
8 BODY CLEANSER 1 0.0014
9 LEMBOREXANT 4 0.0014
See all drugs enriched for association with IMMOBILISATION SYNDROME